I try to watch as few ads and Public Service Announcements as possible, and I admit I haven’t seen the new video from the International Diabetes…
Tag: JDRF
JDRF has announced a two partnerships to support the development soluble glucagon formulations—an important step toward the advancement of future generation, fully automated and multi-hormonal artificial pancreas systems for people with type 1 diabetes (T1D).
JDRF and Tandem Diabetes Care, the company behind the t:slim insulin pump, have teamed up to develop a dual-chamber infusion pump for the management of diabetes. The partnership agreement is designed to accelerate the development of a next-generation, fully automated artificial pancreas system.
The European Association for the Study of Diabetes (EASD) annual meeting is being held in Berlin right now, and yesterday I received a JDRF press…
JDRF and Dexcom announced that they have formed a partnership whose goal is to accelerate the development of a novel wireless “smart transmitter” that would allow a continuous glucose monitor (CGM) system to communicate directly with an artificial pancreas...
On Feb. 18 I moderated the JDRF Capitol Chapter’s second annual Research Summit on Type 1 Diabetes...
The U.S. Food and Drug Administration (FDA) has approved the first outpatient artificial pancreas trial in the United States, marking a critical development in the effort by JDRF and its allies to bring this innovative and lifesaving diabetes technology to people with type 1 diabetes...
JDRF-funded researchers have begun enrolling adult patients with type 1 diabetes in the REMOVAL study, to test whether metformin-a drug commonly used to treat type 2 diabetes-could help prevent or reduce the risk of cardiovascular complications in people with type 1 diabetes...
The U.S. Food and Drug Administration (FDA) issued draft guidance designed to help investigators and manufacturers as they develop and seek approval for artificial pancreas device systems to treat type 1 diabetes. This step comes after a large campaign led by the Juvenile Diabetes research Foundation ...
This is not a story about statistics, yet I have to start there. It is not a story about a shocking ad that ran in the New York Times and Washington…